{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:26:51Z","timestamp":1783002411950,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10286-018-0564-5","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T14:53:28Z","timestamp":1537282408000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Substantial renal conversion of l-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-6095","authenticated-orcid":false,"given":"Guillaume","family":"Lamotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000054725","volume":"90","author":"T Akizawa","year":"2002","unstructured":"Akizawa T, Koshikawa S, Iida N, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M, Tubakihara Y (2002) Clinical effects of l-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Nephron 90:384\u2013390","journal-title":"Nephron"},{"key":"564_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"61","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, Biaggioni I (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 61:701\u2013706","journal-title":"Hypertension"},{"key":"564_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","volume":"65","author":"I Biaggioni","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H (2015) Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 65:101\u2013107","journal-title":"Hypertension"},{"key":"564_CR4","first-page":"580","volume":"76","author":"I Biaggioni","year":"1993","unstructured":"Biaggioni I, Garcia F, Inagami T, Haile V (1993) Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab 76:580\u2013586","journal-title":"J Clin Endocrinol Metab"},{"key":"564_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0140-6736(87)91317-1","volume":"2","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170\u20131172","journal-title":"Lancet"},{"key":"564_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1258\/000456307780945705","volume":"44","author":"DF Davidson","year":"2007","unstructured":"Davidson DF, Grosset K, Grosset D (2007) Parkinson\u2019s disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites. Ann Clin Biochem 44:364\u2013368","journal-title":"Ann Clin Biochem"},{"key":"564_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1527-3466.2006.00189.x","volume":"24","author":"DS Goldstein","year":"2006","unstructured":"Goldstein DS (2006) L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev 24:189\u2013203","journal-title":"Cardiovasc Drug Rev"},{"key":"564_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0091270010363476","volume":"51","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Holmes C, Sewell L, Pechnik S, Kopin IJ (2011) Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS. J Clin Pharmacol 51:66\u201374","journal-title":"J Clin Pharmacol"},{"key":"564_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S (2014) Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A). J Parkinsons Dis 4:57\u201365","journal-title":"J Parkinsons Dis"},{"key":"564_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0378-4347(93)E0430-X","volume":"653","author":"C Holmes","year":"1994","unstructured":"Holmes C, Eisenhofer G, Goldstein DS (1994) Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653:131\u2013138","journal-title":"J Chromatogr B Biomed Appl"},{"key":"564_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1373\/clinchem.2009.139709","volume":"56","author":"C Holmes","year":"2010","unstructured":"Holmes C, Whittaker N, Heredia-Moya J, Goldstein DS (2010) Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde. Clin Chem 56:832\u2013838","journal-title":"Clin Chem"},{"key":"564_CR12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cphy.c100043","volume":"1","author":"EJ Johns","year":"2011","unstructured":"Johns EJ, Kopp UC, DiBona GF (2011) Neural control of renal function. Compr Physiol 1:731\u2013767","journal-title":"Compr Physiol"},{"key":"564_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-4347(00)83871-2","volume":"429","author":"B Kagedal","year":"1988","unstructured":"Kagedal B, Goldstein DS (1988) Catecholamines and their metabolites. J Chromatogr 429:177\u2013233","journal-title":"J Chromatogr"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ (2014) Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83:328\u2013335","journal-title":"Neurology"},{"key":"564_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2015) Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther 13:875\u2013891","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"564_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","volume":"108","author":"H Kaufmann","year":"2003","unstructured":"Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724\u2013728","journal-title":"Circulation"},{"key":"564_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13427","author":"J Kong","year":"2018","unstructured":"Kong J, Davies M, Mount P (2018) The importance of residual kidney function in haemodialysis patients. Nephrology (Carlton, Vic.). https:\/\/doi.org\/10.1111\/nep.13427","journal-title":"Nephrology (Carlton, Vic.)"},{"key":"564_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ana.410180505","volume":"18","author":"JG Nutt","year":"1985","unstructured":"Nutt JG, Woodward WR, Anderson JL (1985) The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism. Ann Neurol 18:537\u2013543","journal-title":"Ann Neurol"},{"key":"564_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0303-8467(75)80014-X","volume":"78","author":"T Siirtola","year":"1975","unstructured":"Siirtola T, Sonninen V, Rinne UK (1975) Urinary excretion of monoamines and their metabolites in patients with Parkinson\u2019s disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations. Clin Neurol Neurosurg 78:77\u201388","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-018-0564-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T21:05:00Z","timestamp":1662066300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-018-0564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s10286-018-0564-5","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}